drugset / Trial / NCT07369895
Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma
NaSequentialOpen-labelTreatment
Summary
This study is a single-center, open and dose-escalation clinical study to evaluate the safety, tolerability, PK/PD characteristics and preliminary efficacy of the investigational drug O\&D-001 injection in the treatment of relapsed or refractory multiple myeloma.
Timeline
- Start
- 2025-10-28
- Primary completion
- 2028-03-28
- Completion
- 2028-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | O&D-001 | Cell therapy | — | Intravenous |